Dr. Tashko's 3D-rendered digital illustration in soft blue tones depicting the intersection of PCOS and insulin resistance using a Venn diagram. The image includes a stylized ovary on the left and an insulin-related molecular shape on the right, connected by a sine wave representing hormonal imbalance.

Polycystic ovary syndrome (PCOS) and insulin resistance often go hand in hand. In fact, insulin resistance plays a central role in the development and worsening of PCOS symptoms. For many women, understanding this connection can open the door to more effective, personalized care.

What Is PCOS?

PCOS is a common hormonal condition that affects women of reproductive age. Its symptoms often include:

  • Irregular or absent periods
  • Excess facial or body hair
  • Ovarian cysts
  • Weight gain, especially around the belly
  • Acne or oily skin
  • Infertility

PCOS is a diagnosis of exclusion, often based on a combination of symptoms, lab findings (such as elevated androgens), and ultrasound results. However, one of the most powerful and modifiable drivers of PCOS is insulin resistance.

What Is Insulin Resistance?

Insulin is the hormone that helps move glucose from the bloodstream into the body’s cells. When someone has insulin resistance, the body doesn’t respond well to insulin. To compensate, the pancreas produces more insulin, leading to hyperinsulinemia—high insulin levels in the blood.

Over time, this can cause a cascade of issues:

  • Increased fat storage
  • Higher androgen production by the ovaries
  • Disrupted menstrual cycles
  • Increased inflammation
  • Elevated blood sugar and triglycerides

As a result, insulin resistance can worsen the metabolic and reproductive features of PCOS.

How Are PCOS and Insulin Resistance Linked?

Research suggests that at least 50% to 70% of women with PCOS have insulin resistance, even if they are not overweight. In fact, lean women with PCOS can still experience significant insulin signaling issues at the cellular level.

High insulin levels increase ovarian androgen production. This leads to symptoms such as:

  • Irregular ovulation or anovulation
  • Hirsutism (unwanted hair growth)
  • Cyst formation
  • Oily skin and acne

In turn, these hormonal imbalances worsen insulin resistance—a vicious cycle that can be hard to break without a thoughtful, strategic plan.

Shared Symptoms and Overlapping Risks

Because of their overlap, PCOS and insulin resistance share many symptoms:

  • Weight gain and central adiposity
  • Acanthosis nigricans (darkened skin folds)
  • Elevated triglycerides and LDL
  • Low HDL
  • Elevated fasting insulin or glucose
  • Increased risk of type 2 diabetes
A 3D medical illustration showing the bidirectional relationship between PCOS (Polycystic Ovary Syndrome) and insulin resistance. On the left, a stylized ovary with cysts represents PCOS. On the right, a syringe and a hexagon labeled "GLUCOSE" represent insulin resistance. Two curved arrows between the circles emphasize their mutual reinforcement, illustrating how each condition can exacerbate the other in a metabolic cycle. The design uses a clean blue background and vibrant icons for educational clarity.

In addition, women with both conditions face a higher long-term risk of:

  • Cardiovascular disease
  • Gestational diabetes
  • Non-alcoholic fatty liver disease (NAFLD)
  • Endometrial hyperplasia

A Smart Strategy for Care

The good news is that insulin resistance is highly modifiable. Addressing it directly can significantly improve PCOS outcomes—both for metabolic health and hormonal balance.

At our Montgomery County, Maryland practice, we offer personalized care tailored to each woman’s root issues. Whether weight, sleep, stress, or nutrient status is the driving factor, we approach PCOS from multiple angles.

Key elements of care may include:

1. Nutrition

  • Emphasizing low-glycemic, fiber-rich foods
  • Reducing added sugars and refined carbohydrates
  • Encouraging healthy fats and protein at every meal

2. Physical Activity

  • Prioritizing strength training and movement throughout the day
  • Aiming for 150 minutes of moderate activity per week

3. Targeted Supplementation

  • Inositol (myo- and D-chiro forms) for insulin sensitivity
  • Vitamin D, magnesium, and omega-3s for metabolic support

4. Metformin or GLP-1 Medications

  • Used thoughtfully in select patients to improve insulin action and promote weight loss when appropriate

5. Sleep and Stress

  • Addressing these factors for cortisol balance, which also affects insulin signaling

6. Hormonal Monitoring

  • Tracking testosterone, LH/FSH ratios, DHEA, insulin, and HbA1c over time

Why Holistic, Individualized Care Matters

PCOS and insulin resistance do not exist in isolation. They affect and are affected by nearly every system in the body—from the gut to the brain. That’s why holistic care makes a real difference.

By addressing insulin resistance, we can:

  • Improve ovulation and menstrual cycles
  • Reduce unwanted hair growth and acne
  • Support fertility
  • Lower long-term diabetes and cardiovascular risks

In our experience, approaching PCOS with a balanced viewpoint and a common-sense approach leads to better outcomes. Every woman’s body tells a different story, and we listen carefully to each one.

Summary Table

Key PointExplanation
PCOS affects hormone balanceAndrogens increase, cycles become irregular, cysts may form
Insulin resistance fuels PCOSHigh insulin raises androgens, worsening PCOS symptoms
Shared symptomsWeight gain, acne, hirsutism, infertility, metabolic changes
Modifiable with lifestyle careDiet, movement, and stress control can lower insulin and improve PCOS
Medications may help when neededMetformin and GLP-1 agonists can reduce insulin resistance and weight
Holistic care is essentialWe treat PCOS from multiple angles for long-term success

Dr. Tashko

  1. Insulin Resistance in Polycystic Ovary Syndrome Across Various Tissues: An Updated Review of Pathogenesis, Evaluation, and Treatment. Zhao H, Zhang J, Cheng X, Nie X, He B. Journal of Ovarian Research. 2023;16(1):9. doi:10.1186/s13048-022-01091-0.
  2. Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance. Herman R, Sikonja J, Jensterle M, Janez A, Dolzan V. International Journal of Molecular Sciences. 2023;24(4):3140. doi:10.3390/ijms24043140.
  3. Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications. Diamanti-Kandarakis E, Dunaif A. Endocrine Reviews. 2012;33(6):981-1030. doi:10.1210/er.2011-1034.
  4. Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†. Teede HJ, Tay CT, Laven J, et al. Human Reproduction (Oxford, England). 2023;38(9):1655-1679. doi:10.1093/humrep/dead156.
  5. Insulin Resistance in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Euglycaemic-Hyperinsulinaemic Clamp Studies. Cassar S, Misso ML, Hopkins WG, et al. Human Reproduction (Oxford, England). 2016;31(11):2619-2631. doi:10.1093/humrep/dew243.
  6. Insulin Resistance and Polycystic Ovary Syndrome. Moghetti P. Current Pharmaceutical Design. 2016;22(36):5526-5534. doi:10.2174/1381612822666160720155855.

About Dr. Gerti Tashko, MD

Dr. Gerti Tashko, MD, is an endocrinologist in Montgomery County, Maryland. He is uniquely quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice delivers root-cause-focused metabolic and endocrine care, available virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to improve long-term health.